WADA EXECUTIVE COMMITTEE APPROVES 2005 PROHIBITED LIST

WADA EXECUTIVE COMMITTEE APPROVES 2005 PROHIBITED LIST

By ITU Admin on 25/09/04 at 12:00 am

The World Anti-Doping Agency (WADA) announced recently that its Executive Committee
approved the Prohibited List of Substances and Methods for 2005. The new List
will be published prior to October 1, 2004, and will go into effect January 1,
2005.

Some changes will be made from the current List in 2005. For example, the topical   application of glucocorticosteroids will no longer require an abbreviated therapeutic   use exemption. Beta-2 agonists, often used in the treatment of asthma, will   now be prohibited both in and out of competition.
 
  Due to the findings of a WADA-sponsored research project, Finasteride, a product   used for prostate problems in men and also for hair loss, will be added to the   Prohibited List as a masking agent.

Finally, intravenous infusion for non-medical purposes will now be explicitly   banned.The Executive Committee based its decisions regarding the List on the   recommendations of WADAs List Committee and Health-Medical and Research   Committee, which met in September to discuss the 2005 List. Since 2004, WADA   has been tasked with issuing the List on an annual basis, a responsibility previously   held by the International Olympic Committee (IOC).

A substance or method is added to the List if it meets two of three criteria:   it is performance enhancing, poses a danger to athletes health, and its   use is against the spirit of sport.Refining the List is an important   part of WADAs responsibilities under the World Anti-Doping Code,   said Richard W. Pound, WADAs president. The changes we have made   this year reflect our expanding scientific knowledge and our ability to better   identify performance enhancing substances and methods.

For complete WADA information visit: http://www.wada-ama.org/en/t1.asp  

Responses to "WADA EXECUTIVE COMMITTEE APPROVES 2005 PROHIBITED LIST"

Tracker Pixel for Entry